Organon & Co. (OGN)
Makes contraception, fertility, and women's health medicines and devices globally.
$13.54+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+38.9%
The outlook
OGN is trading near its 52-week high, well above both its 50- and 200-day moving averages, reflecting upward momentum. However, the average analyst price target sits roughly 17% below the current price, suggesting caution despite the bullish technical setup. The stock trades at a trailing P/E of 14.6, in line with many healthcare peers.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Price targetAvg target -17% vs current price
Analyst price target
~12-month · 4 analysts$11.25average target-16.9% vs now
Now $13.54
Low $8.00High $14.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.56B
52-wk high
$13.60
52-wk low
$5.69
50-day avg
$13.45
200-day avg
$9.46
Trailing P/E
14.6